Isoprinosine Ewopharma

Inosine Pranobex, the active ingredient in Isoprinosine Ewopharma, is an immunomodulator presented as an oral formulation for oral use. It is used to support the immune system and to treat certain viral infections in adults and children. GNH USA supplies Isoprinosine Ewopharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoprinosine Ewopharma contains Inosine Pranobex, an immunomodulator that acts on viral replication and host immune response. - Influenza: helps reduce severity and duration of flu symptoms. - Herpes simplex infection: accelerates healing of oral and genital lesions. - Respiratory viral infections (e.g., RSV, adenovirus): supports viral clearance and symptom relief. - Immunodeficient conditions: provides immunostimulatory support to improve host defense.

Adverse reactions may occur with Inosine Pranobex therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Abdominal pain: cramp‑like discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis or angioedema. - Leukopenia: marked reduction in white blood cells. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Thrombocytopenia: low platelet count leading to bleeding risk.

Before initiating therapy, consider the following safety measures. - Pregnancy: safety not established; use only if potential benefit justifies risk. - Breastfeeding: unknown excretion; weigh infant risk versus maternal benefit. - Renal impairment: monitor renal function and adjust if necessary. - Hepatic disease: assess liver enzymes regularly. - Immunocompromised patients: observe closely for opportunistic infections. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Inosine Pranobex may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Immunosuppressants: may diminish antiviral and immunostimulatory effects. - Live vaccines: increased risk of vaccine‑derived infection.

Moderate Interactions (Monitor Closely): - Anticoagulants: potential for enhanced bleeding tendency. - Corticosteroids: additive immunomodulatory actions may alter response. - Antihistamines: could mask early signs of allergic reactions.